Literature DB >> 12035876

Microalbuminuria is related to marked end organ damage in previously untreated, elderly hypertensive patients.

W F Terpstra1, J F May, A J Smit, P A de Graeff, H J G M Crijns.   

Abstract

We wondered whether, in an elderly hypertensive population in a primary prevention setting, free from diabetes mellitus and clinical atherosclerosis, differences between end organ damage and microalbuminuria (MA) could be found using a lower level of urinary albumin excretion than that of classically defined MA. From a population survey of 173 previously untreated hypertensive patients (4x blood pressure systolic > or = 160 and < or = 220 mmHg, and/or diastolic > or = 95 and < or = 115 mmHg), mean age 67 +/- 4 years, were screened for MA (defined as albumin excretion between 20 and 300 mg/24 h). End organ damage was determined by B-mode ultrasound scanning of carotid and femoral arteries and echocardiography. Out of 173 hypertensives, 14 showed MA (8%). These hypertensives had a significantly higher intima media thickness (IMT; 1.01 +/- 0.21 vs 0.88 +/- 0.6 mm, p < 0.05) and increased left ventricular mass index (118 +/- 31 vs 103 +/- 22 g/m2, p < 0.05) than hypertensives without MA. Linear regression analysis showed that MA, age, male gender and diastolic blood pressure were independently related to IMT, while systolic blood pressure, male gender and body mass index were independently related to left ventricular mass. Even using lower levels of urinary albumin excretion rate, patients with MA had significantly higher IMT and increased left ventricular mass. Moreover, MA was independently related to IMT in these elderly hypertensives. These results suggest that the threshold value for MA should be reconsidered in hypertension.

Entities:  

Mesh:

Year:  2002        PMID: 12035876     DOI: 10.1080/08037050211267

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  4 in total

1.  Hypertension in perspective.

Authors:  W F Terpstra; F Zijlstra
Journal:  Neth Heart J       Date:  2005-05       Impact factor: 2.380

Review 2.  Microalbuminuria in hypertension.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

3.  Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.

Authors:  Cornelis Boersma; Maarten J Postma; Sipke T Visser; Jarir Atthobari; Paul E de Jong; Lolkje T W de Jong-van den Berg; Ron T Gansevoort
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

4.  Association between microalbuminuria and subclinical atherosclerosis evaluated by carotid artery intima-media in elderly patients with normal renal function.

Authors:  XiangLei Kong; XiaoYan Jia; Yong Wei; MeiYu Cui; ZunSong Wang; LiJun Tang; WenBin Li; ZhuXian Zhu; Ping Chen; DongMei Xu
Journal:  BMC Nephrol       Date:  2012-06-11       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.